Ledger.Open graph →

SEC Form D · filed December 1, 2016

ACON BioMatrix Investors I, L.L.C

Offering

$57.5M

Sold

$57.5M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

WASHINGTON, Washington, D.C.

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Daniel R. Jinich · WASHINGTON, Washington, D.C.Exec Teresa R. Bernstein · WASHINGTON, Washington, D.C.Exec Andre R. Bhatia · Washington DC, Washington, D.C.Exec Bernard R. Aronson · Washington DC, Washington, D.C.Exec Barry R. Johnson · WASHINGTON, Washington, D.C.Exec Jonathan R. Ginns · Washington DC, Washington, D.C.Exec Aron R. Schwartz · WASHINGTON, Washington, D.C.Exec Kenneth R. Brotman · Washington DC, Washington, D.C.Exec Stephen Ho · VANCOUVER, British Columbia, CanadaExec Acon Equity Management, L.L.C · WASHINGTON, Washington, D.C.Exec William G. Pigeon · LAFAYETTE, CAExec Teresa R. Bernstein · WASHINGTON, Washington, D.C.Exec Andre R. Bhatia · WASHINGTON, Washington, D.C.Exec Bernard R. Aronson · WASHINGTON, Washington, D.C.Exec Barry R. Johnson · WASHINGTON, Washington, D.C.Exec Jonathan R. Ginns · WASHINGTON, Washington, D.C.Exec Aron R. Schwartz · WASHINGTON, Washington, D.C.Exec Kenneth R. Brotman · Washington DC, Washington, D.C.Exec Acon Equity Management, L.L.C · WASHINGTON, Washington, D.C.Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗